Quest Diagnostics To Speak At The 31st Annual J.P. Morgan Healthcare Conference

     Quest Diagnostics To Speak At The 31st Annual J.P. Morgan Healthcare
                                  Conference

PR Newswire

MADISON, N.J., Jan. 8, 2013

MADISON, N.J., Jan. 8, 2013 /PRNewswire/ --Quest Diagnostics Incorporated
(NYSE: DGX), the world's leading provider of diagnostic information services,
announced that it is scheduled to speak at the 31^st Annual J.P. Morgan
Healthcare Conference in San Francisco. The presentation is scheduled for
Wednesday, January 9, 2013 at 2:30 p.m. Eastern Time.

The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticker=DGX
and to the public on www.QuestDiagnostics.com/investor. In addition, the
archived webcast will be available within 24 hours after the conclusion of the
live event and will remain available until February 9, 2013.

Quest Diagnostics is the world's leading provider of diagnostic information
services that patients and doctors need to make better healthcare decisions.
The company offers the broadest access to diagnostic testing services through
its network of laboratories and patient service centers, and
providesinterpretive consultation through its extensive medical and
scientific staff. Quest Diagnostics is a pioneer in developing innovative
diagnostic tests and advanced healthcare information technology solutions that
help improve patient care. Additional company information is available at
QuestDiagnostics.com.

Contacts:
Kathleen Valentine (Investors): 973-520-2900
Wendy Bost (Media): 973-520-2800

SOURCE Quest Diagnostics Incorporated

Website: http://www.questdiagnostics.com
 
Press spacebar to pause and continue. Press esc to stop.